Differentially expressed genes in the high-risk group were mainly associated with the regulation of the immune response, the hypoxia-inducible factor-1 (HIF-1) signalling pathway, and the tumour PD-1/PD-L1 immune checkpoint pathway. The gene discussed is CD274; the disease is neoplasm.